ClinicalTrials.Veeva

Menu

Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Study type

Observational

Funder types

Other

Identifiers

NCT00711724
2007-P-000911

Details and patient eligibility

About

The primary objective is to establish the concurrent validity of the clinician administered Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS) and the patient administered Attention Deficit Hyperactivity Disorder Self Report Scale (ASRS) v1.1 Symptom Checklist.

Enrollment

50 estimated patients

Sex

All

Ages

13 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of ADHD
  • Age 13-65* *Parental consent and patient's assent will be obtained for minors participating in this protocol (only adolescents aged 13-18 yrs old will be included in the MGH site)

Exclusion criteria

  • Inability to reliably report ADHD symptoms at the discretion of the investigator

Trial design

50 participants in 1 patient group

MGH 1
Description:
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems